Sponsors
The bill shifts authority over which drugs require prescriptions to the states—increasing local control and preserving federal oversight for abortion drugs—while risking uneven access, weaker protections in some states, and higher compliance costs for providers.
State governments and healthcare providers: State law will determine which drugs require prescriptions, giving states greater local control and the ability to align prescribing rules with state medical practice standards.
Pregnant people and providers of abortion care: The federal Secretary retains authority to regulate drugs used to terminate pregnancy, preserving a federal safety/regulatory backstop for that drug category.
Patients with chronic conditions and people who rely on consistent drug access: Access to medicines could vary by state, producing a patchwork of rules that makes it harder for some patients to obtain drugs that were previously regulated uniformly by the FDA.
Patients and healthcare providers in states with looser rules: Consumers may face reduced federal protections and oversight for prescription drug safety in some states, increasing risks related to weaker regulatory standards.
Pharmacies, clinicians, and health systems operating across state lines: Differing state definitions of which drugs require prescriptions will increase compliance complexity and administrative costs for providers and pharmacies.
Based on analysis of 2 sections of legislative text.
Introduced January 3, 2025 by Andrew S. Biggs · Last progress January 3, 2025
Repeals the federal prescription-definition provisions in the Food, Drug, and Cosmetic Act six months after enactment and directs federal officials to interpret the terms “prescribing,” “prescription,” and related requirements according to each State's law after that date. The Secretary of Health and Human Services may, however, continue to apply the repealed federal prescription rules for any drug intended to terminate a pregnancy. The change shifts the baseline for federal drug-regulation language from a single federal definition to whatever each State's law provides, which could create different prescribing standards across states and affect patients, clinicians, pharmacies, manufacturers, and federal regulators.